Covered recipient · General Payments record
ELIZABETH M WULFF
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$25,701.64
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,310.00 | 2 |
| Travel and Lodging | $1,432.42 | 7 |
| Food and Beverage | $808.39 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $4,982.88 | 12 |
| E.R. Squibb & Sons, L.L.C. | $2,036.95 | 2 |
| PFIZER INC. | $278.49 | 2 |
| AVEO Pharmaceuticals, Inc. | $252.49 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aveo Pharmaceuticals, Inc. | $117.62 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143477132 | CMS |
| Aveo Pharmaceuticals, Inc. | $134.87 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143477120 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.95 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101591384 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,010.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101591349 | CMS |
| Exelixis Inc. | $70.00 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557513 | CMS |
| Exelixis Inc. | $351.97 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557515 | CMS |
| Exelixis Inc. | $483.36 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557517 | CMS |
| Exelixis Inc. | $274.00 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557519 | CMS |
| Exelixis Inc. | $103.10 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138557521 | CMS |
| Exelixis Inc. | $55.06 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138557525 | CMS |
| Exelixis Inc. | $50.00 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557529 | CMS |
| Exelixis Inc. | $13.08 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557531 | CMS |
| Exelixis Inc. | $190.01 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138557533 | CMS |
| Exelixis Inc. | $75.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138557523 | CMS |
| Exelixis Inc. | $16.68 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138557527 | CMS |
| Exelixis Inc. | $3,300.00 | 05/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1138557511 | CMS |
| PFIZER INC. | $135.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131478484 | CMS |
| PFIZER INC. | $143.49 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131348679 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.